Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07850141 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Prospective Registry of Exposure to Gepotidacin (PREG)

StatusNot Yet Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
GlaxoSmithKline
246 trials monitored
See 20 trials at risk
The purpose of this study is to monitor pregnancies exposed to gepotidacin and to evaluate possible teratogenic effects or birthweight-lowering effects of this medication relative to the primary outcomes of major congenital malformations (MCMs) and small for gestational age (SGA), as well as to evaluate secondary maternal, fetal, and infant outcomes.
Trial Details
NCT Number NCT07850141
Lead Sponsor GlaxoSmithKline
Collaborators: PPD Observational Studies (part of Thermo Fisher Scientific, Inc.)
Conditions
(from sponsor)		 Sexually Transmitted Diseases
Related terms Sexually Transmitted Diseases, Urinary Tract Infections
Enrollment 614 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov